Expected | Best selling drugs of 2024 | Top selling drugs of 2024 | iPharmaCenter

1. Keytruda: Revolutionizing Cancer Care Keytruda (pembrolizumab), an immunotherapy drug by Merck, has transformed cancer treatment....

European Congress of Rheumatology, EULAR 2024 | News | Updates | iPharmaCenter

New Study Identifies Corticosteroid Management as Predictors of Organ Damage in Children with Lupus Childhood-onset systemic lupus...

Top pharma companies by revenues in 2023| Best Selling Drugs of 2023 |Top 20 pharma companies | iPharmaCenter

TOP PHARMACEUTICAL COMPANIES BY REVENUES 2023 Merck revenues exclude animal health revenues 1. JOHNSON AND JOHNSON Q1 REVENUES Johnson...

December 21, 2023 Takeda's Livtencity was approved in China for CMV infections Takeda declares the approval from China NMPA for...

India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter

September 26, 2023 Cipla initiated drone services to deliver medicines to difficult-to-reach terrains. Cipla Limited has unveiled an...

Health Canada Drug Approvals | Healthcare and Pharmaceutical News of Canada | News | Blogs | Canada

September 27, 2023 Sun Pharma's Winlevi approved for acne Sun Pharma has introduced a new topical treatment for acne called Winlevi,...

LATEST

View all

Best selling immunology drugs by revenues | Top immunology drugs | 2024 | iPharmaCenter

Dupixent - $6.8 billion Stelara - $5.3 billion Humira - $ 5.0 billion Skyrizi - $4.7 billion Cosentyx - $2.9 billion Entyvio - $2.9...

Top selling cancer drugs of 2024 | Best selling cancer drugs | Top cancer drugs by revenues in 2024 | iPharmaCenter

Keytruda - $7.3 billion Darzalex - $5.6 billion Opdivo - $4.5 billion Tagrisso - $3.2 billion Revlimid - $3.0 billion Verzenio - $2.4...

Top pharmaceutical companies by revenues in 2024 | Biggest Pharma of 2024 | Top Pharma profits | iPharmaCenter

TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2024 1. JOHNSON AND JOHNSON Q1 REVENUES: In the first quarter of 2024, Johnson & Johnson...

Expected | Best selling drugs of 2024 | Top selling drugs of 2024 | iPharmaCenter

1. Keytruda: Revolutionizing Cancer Care Keytruda (pembrolizumab), an immunotherapy drug by Merck, has transformed cancer treatment....

LEQEMBI (Lecanemab) Receives Approval in Israel for Treating Alzheimer's Disease | iPharmaCenter

Eisai and Biogen have announced that their humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody, LEQEMBI (lecanemab),...

Pharmaceutical deals | Acquistions | 2024 | iPharmaCenter

Overview NovoNordisk Collaboration with Omega Therapeutics and Cellarity Novartis and Voyager Collaboration to Develop Gene Therapies for...

US FDA NEWS

EUROPE

FDA Grants Accelerated Approval to Gilead’s Livdelzi for PBC, Marking Breakthrough in Liver Disease Treatment | iPharmaCenter

Gilead announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi (seladelpar) as a...

Novartis Gains FDA Accelerated Approval for Fabhalta (iptacopan), a Complement Inhibitor for Reducing Proteinuria in Primary IgA Nephropathy (IgAN)

Fabhalta demonstrated a 44% reduction in proteinuria during the Phase III APPLAUSE-IgAN interim analysis, compared to a 9% reduction with...

FDA Approved Sun Pharma's Leqselvi (deuruxolitinib) for Severe Alopecia Areata

Leqselvi shows significant effectiveness in two Phase 3 clinical trials. Initially, patients had only 13% scalp hair coverage, but after...

US FDA Approves Expanded Use of Jemperli Plus Chemotherapy for Endometrial Cancer

GSK announced that the US Food and Drug Administration (FDA) has approved the use of Jemperli (dostarlimab) combined with carboplatin and...

FDA Approves Lilly's Kisunla for Early Symptomatic Alzheimer's Disease

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved Kisunla (donanemab), a treatment developed by Eli...

Imfinzi approved for mismatch repair deficient endometrial cancer, fifth indication for AZ's blockbuster | iPharmaCenter

Imfinzi Combined with Chemotherapy Gains US Approval for Advanced or Recurrent Endometrial Cancer with Mismatch Repair Deficiency...

INDIA

European Commission Greenlights Keytruda and Padcev Combo as First-Line Treatment for Advanced Urothelial Carcinoma | iPharmaCenter

Merck's Keytruda (pembrolizumab), combined with Padcev (enfortumab vedotin), has received approval from the European Commission (EC) as a...

European Commission Expands Approval for GSK's Arexvy, the First RSV Vaccine for Adults Aged 50-59 at Increased Risk | iPharmaCenter

In a significant development, the European Commission has expanded the approval of Arexvy, GSK's respiratory syncytial virus (RSV)...

Roche aims PNH market with SC PiaSky, aims to target AZ's Ultomiris market | iPharmaCenter

EU Approval for Roche’s PiaSky as First Monthly Subcutaneous Treatment for PNH Roche has announced that the European Commission has...

European Union Approves Ordspono for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma | iPharmaCenter

Regeneron Pharmaceuticals has announced that the European Commission (EC) has granted approval for Ordspono (odronextamab) for the...

Leqembi (lecanemab) Approved in Great Britain for Early-Stage Alzheimer's Disease | iPharmaCenter

Great Britain has granted approval for Leqembi (lecanemab), a treatment designed for adults with mild cognitive impairment (MCI) and...

The European Commission Grants Approval for Tepkinly for a New Indication in Treating Relapsed/Refractory Follicular Lymphoma in Adults | iPharmaCenter

Tepkinly (epcoritamab) has received conditional marketing authorization from the European Commission (EC) as a monotherapy for treating...

CHINA

Sanofi Secures Approval for Beyfortus in India to Shield Infants and Children from RSV | iPharmaCenter

Sanofi India announced the receipt of marketing authorization for Beyfortus (nirsevimab) from the Central Drugs Standard Control...

Indian Pharma News | 2024 | iPharmaCenter

May 21, 2024 Glenmark and BeiGene Collaborate to Market and Distribute Tislelizumab and Zanubrutinib in India Key Points: Tislelizumab:...

19th January, 2024 Tirzepatide Recommended alongside dietary adjustments and physical activity to enhance blood sugar management in...

China's NMPA Grants Approval for Padcev (Enfortumab Vedotin) for Advanced Urothelial Cancer | iPharmaCenter

China’s National Medical Products Administration (NMPA) has officially approved Padcev (enfortumab vedotin) for the treatment of adult...

Enhertu Receives Conditional Approval in China for Advanced HER2-Positive Gastric Cancer | iPharmaCenter

Enhertu, developed by AstraZeneca and Daiichi Sankyo, has gained conditional approval in China for use in patients with advanced or...

HUTCHMED's NDA for Tazemetostat in China Receives Priority Review for Relapsed/Refractory Follicular Lymphoma | iPharmaCenter

HUTCHMED (China) Limited has announced that the New Drug Application (NDA) for tazemetostat, aimed at treating adult patients with...

HEALTHCARE SYSTEMS

Brazil Healthcare System | How Brazil's healthcare work? Funding | How are drugs approved and reimbursed? | iPharmaCenter

Overview According to data from the Brazilian Federation of Hospitals (FBH) and the National Confederation of Health (CNSaúde), out of...

Vietnam Healthcare System | Drug regiatration and approvals | iPharmaCenter

The healthcare system in Vietnam is a dynamic combination of both public and private sectors, focusing on preventive medicine and...

Indonesia Healthcare System | Healthcare System | iPharmaCenter

OVERVIEW Indonesia has highest population after China, India, and USA, with a population of over 270 million people. The country's...

Saudi Arabia | Healthcare System | Drug approvals and pricing | iPharmaCenter

OVERVIEW Saudi Arabia accounts for two-thirds of the GCC population and is the largest healthcare market in the region. While it accounts...

MEXICO HEALTHCARE SYSTEM | DRUG PRICING AND REIMBURSEMENT IN MEXICO | NEWS | BLOGS | iPharmaCenter

OVERVIEW OF MEXICO HEALTHCARE SYSTEM Article 4 of Mexico's constitution guarantees the right to health for all citizens. Mexico has a...

INDIAN HEALTHCARE SYSTEM | HEALTHCARE SYSTEM OF INDIA | NEWS | BLOGS | IPHARMACENTER

DEMOGRAPHICS The constitution of India ensures the "right to health" for every citizen. It is the responsibility of the state governments...

HEALTHCARE SYSTEM IN CHINA

Overview of China healthcare system China achieved universal health coverage in 2011. The urban employed is covered via an...

Drug pricing and reimbursement in Germany | Health Technology Assessment in Germany

It is mandatory to have health insurance in Germany. Statutory Health Insurance covers 90% of the German population, and the rest, 10%,...

Why the cost of prescription drugs is high in the US?

The United States spends more on prescription drugs compared to other developed nations. On average, the United States spends as much as...